The CCR5 (-2135C/T) polymorphism may be associated with the development of kawasaki disease in Korean children

Journal of Clinical Immunology

Volumn 29, Issue 1, 2009, Pages 22-28

  Jhang, Won Kyoung ^a   Kang, Mi Jin ^a   Jin, Hyun Seung ^a   Yu, Jinho ^a   Kim, Byoung Ju ^a   Kim, Bong Seong ^a   Lee, Jong Keuk ^a   Seo, Eul Ju ^a   Yoo, Han Wook ^a   Park, In Sook ^a   Hong, Young Mi ^b   Hong, Soo Jong ^a,c  

^a University of Ulsan College of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

CCR5; Coronary artery aneurysm; Kawasaki disease; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; KOREA; LABORATORY; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL;

ALLELES; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; KOREA; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5;

EID: 59449086241     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-008-9218-z     Document Type: Article

References (40)

1. A Desai S Patel W Book 2005 "Myocardial infarction" in adolescents: do we have the correct diagnosis? Pediatr Cardiol 26 627 31 doi:10.1007/s00246-004-0864-5
2. JC Burns 2002 Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967 Pediatr Infect Dis J 21 993 5 doi:10.1097/00006454-200211000-00002
3. D Burgner A Harnden 2005 Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis 9 185 94 doi:10.1016/j.ijid. 2005.03.002
4. Y Onouchi M Tamari A Takahashi T Tsunoda M Yashiro Y Nakamura 2007 A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12 J Hum Genet 52 179 90 doi:10.1007/s10038-006-0092-3
5. JW Newburger M Takahashi MA Gerber MH Gewitz LY Tani JC Burns 2004 Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association Pediatrics 114 1708 33
6. M Biezeveld J Geissler M Merkus IM Kuipers J Ottenkamp T Kuijpers 2007 The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease Clin Exp Immunol 147 106 11
7. YH Shim HS Kim S Sohn YM Hong 2006 Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease J Korean Med Sci 21 208 11
8. T Minami H Suzuki T Takeuchi S Uemura J Sugatani N Yoshikawa 2005 A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease J Pediatr 147 78 83 doi:10.1016/j.jpeds.2005.03.037
9. FY Huang TY Chang MR Chen CH Hsu HC Lee SP Lin 2007 Genetic variations of HLA-DRB1 and susceptibility to Kawasaki disease in Taiwanese children Hum Immunol 68 69 74 doi:10.1016/j.humimm.2006.10.018
10. HS Jin HB Kim BS Kim JK Lee EJ Seo HW Yoo 2007 The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease Pediatr Res 61 584 7
11. A Zlotnik O Yoshie 2000 Chemokines: a new classification system and their role in immunity Immunity 12 121 7 doi:10.1016/S1074-7613(00)80165-X
12. C Desmetz YL Lin C Mettling P Portales H Rabesandeatana J Clot 2006 The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density Immunology 119 551 61 doi:10.1111/j.1365-2567.2006.02470.x
13. JC Burns C Shimizu E Gonzalez H Kulkarni S Patel H Shike 2005 Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease J Infect Dis 192 344 9 doi:10.1086/430953
14. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. 1984.Tokyo, Japan: Ministry of Health and Welfare.
15. F Falcini 2006 Kawasaki disease Curr Opin Rheumatol 18 33 8 doi:10.1097/01.bor.0000197998.50450.f6
16. SR Dominguez MS Anderson MP Glodé CC Robinson KV Holmes 2006 Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome J Infect Dis 194 1697 701 doi:10.1086/509509
17. SY Ahn GC Jang JS Shin KM Shin DS Kim 2003 Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea Yonsei Med J 44 1021 6
18. LR Wedderburn N Robinson A Patel H Varsani P Woo 2000 Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis Arthritis Rheum 43 765 74
19. N Suzuki A Nakajima S Yoshino K Matsushima H Yagita K Okumura 1999 Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis Int Immunol 11 553 9 doi:10.1093/intimm/11.4.553
20. TL Sorensen M Tani J Jensen V Pierce C Lucchinetti VA Folcik 1999 Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients J Clin Invest 103 807 15 doi:10.1172/JCI5150
21. S Qin JB Rottman P Myers N Kassam M Weinblatt M Loetscher 1998 The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 746 54 doi:10.1172/JCI1422
22. M Mack H Bruhl R Gruber C Jaeger J Cihak V Eiter 1999 Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis Arthritis Rheum 42 981 8
23. KE Balashov JB Rottman HL Weiner WW Hancock 1999 CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1 alpha and IP-10 are expressed in demyelinating brain lesions Proc Natl Acad Sci U S A 96 6873 8
24. M Samson O Labbe C Mollereau G Vassart M Parmentier 1996 Molecular cloning and functional expression of a new human CC-chemokine receptor gene Biochemistry 35 3362 7
25. H Kato T Sugimura T Akagi N Sato K Hashino Y Maeno T Kazue G Eto R Yamakawa 1996 Long-term consequences of Kawasaki disease A 10- to 21-year follow-up study of 594 patients Circulation 94 1379 85
26. G Koren S Lavi V Rose R Rowe 1986 Kawasaki disease: review of risk factors for coronary aneurysms J Pediatr 108 388 92 doi:10.1016/S0022-3476(86) 80878-2
27. AS Beiser M Takahashi AL Baker RP Sundel JW Newburger 1998 A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group Am J Cardiol 81 1116 20 doi:10.1016/S0002-9149(98) 00116-7
28. M Mori T Imagawa K Yasui A Kanaya S Yokota 2000 Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease J Pediatr 137 177 80 doi:10.1067/mpd.2000.107890
29. Y Morikawa Y Ohashi K Harada T Asai S Okawa M Nagashima 2000 Coronary risks after high dose gamma-globulin in children with Kawasaki disease Pediatr Int 42 464 9 doi:10.1046/j.1442-200x.2000.01288.x
30. VE Honkanen BW McCrindle RM Laxer BM Feldman R Schneider ED Silverman 2003 Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease Pediatr Cardiol 24 122 6 doi:10.1007/s00246-002-0063-1
31. AH Rowley CA Eckerley HM Jack ST Shulman SC Baker 1997 IgA plasma cells in vascular tissue of patients with Kawasaki syndrome J Immunol 159 5946 55
32. TJ Brown SE Crawford ML Cornwall F Garcia ST Shulman AH Rowley 2001 CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease J Infect Dis 184 940 3 doi:10.1086/323155
33. H Senzaki S Masutani J Kobayashi T Kobayashi H Nakano H Nagasaka 2001 Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease Circulation 104 860 3 doi:10.1161/hc3301.095286
34. K Yasukawa M Terai ST Shulman T Toyozaki S Yajima Y Kohno 2002 Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease Circulation 105 766 9 doi:10.1161/hc0602. 103396
35. N Maeno S Takei K Masuda H Akaike K Matsuo I Kitajima 1998 Increased serum levels of vascular endothelial growth factor in Kawasaki disease Pediatr Res 44 596 9 doi:10.1203/00006450-199810000-00021
36. T Asano S Ogawa 2000 Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy Scand J Immunol 51 98 103 doi:10.1046/j.1365-3083.2000.00650.x
37. AF Freeman SE Crawford LS Finn JA Lopez-Andreu S Ferrando-Monleon D Perez-Tamarit 2003 Inflammatory pulmonary nodules in Kawasaki disease Pediatr Pulmonol 36 102 6 doi:10.1002/ppul.10333
38. BA Eberhard U Andersson RM Laxer V Rose ED Silverman 1995 Evaluation of the cytokine response in Kawasaki disease Pediatr Infect Dis J 14 199 203 doi:10.1097/00006454-199503000-00006
39. S Furukawa T Matsubara Y Umezawa K Okumura K Yabuta 1994 Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease J Pediatr 124 721 5 doi:10.1016/S0022-3476(05)81361-7
40. CY Lin CC Lin B Hwang B Chiang 1992 Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease J Pediatr 121 924 6 doi:10.1016/S0022-3476(05)80343-9